96 related articles for article (PubMed ID: 23803371)
1. The activities of acid DNase and 5'nucleotidase in erosive reflux esophagitis and Barrett's epithelium.
Radisavljevic MM; Nagorni AV; Kocic G; Bjelakovic GB; Petrovic AS; Veljkovic AR; Raicevic-Sibinovic SR; Radisavljevic MM
Hepatogastroenterology; 2013; 60(125):1073-6. PubMed ID: 23803371
[TBL] [Abstract][Full Text] [Related]
2. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
[TBL] [Abstract][Full Text] [Related]
4. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Menges M; Müller M; Zeitz M
Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory infiltration of metaplastic epithelium and correlation to previous diagnosis of esophagitis and Barrett's length.
Zampeli E; Karamanolis G; Morfopoulos G; Xirouchakis E; Kalampoki V; Bamias G; Michopoulos S; Savva S; Tzias V; Zouboulis-Vafiadis I; Kamberoglou D; Ladas SD
Scand J Gastroenterol; 2012 Sep; 47(8-9):900-6. PubMed ID: 22630608
[TBL] [Abstract][Full Text] [Related]
8. The clinical biochemistry of 5'-nucleotidase.
Sunderman FW
Ann Clin Lab Sci; 1990; 20(2):123-39. PubMed ID: 2183704
[TBL] [Abstract][Full Text] [Related]
9. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
Singh P; Taylor RH; Colin-Jones DG
Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
[TBL] [Abstract][Full Text] [Related]
10. Ecto 5' nucleotidase (5'NT) as a sensitive indicator of human zinc deficiency.
Meftah S; Prasad AS; Lee DY; Brewer GJ
J Lab Clin Med; 1991 Oct; 118(4):309-16. PubMed ID: 1940572
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of intestinal metaplasia in the gastric cardia.
El-Serag HB; Sonnenberg A; Jamal MM; Kunkel D; Crooks L; Feddersen RM
Am J Gastroenterol; 1999 Mar; 94(3):622-7. PubMed ID: 10086641
[TBL] [Abstract][Full Text] [Related]
12. Decreased ecto-5'nucleotidase activity of peripheral blood lymphocytes in human monoclonal gammopathies: correlation with tumor cell kinetics.
Massaia M; Ma DD; Boccadoro M; Golzio F; Gavarotti P; Dianzani U; Pileri A
Blood; 1985 Mar; 65(3):530-4. PubMed ID: 2982438
[TBL] [Abstract][Full Text] [Related]
13. [Presence of acinar pancreas in reflux esophagitis and Barrett's esophagus].
Mendoza-Ramón H; Goldberg J; Slomianski A; Leal G; Ortiz-Hidalgo C
Rev Gastroenterol Mex; 1998; 63(3):143-7. PubMed ID: 10068760
[TBL] [Abstract][Full Text] [Related]
14. The role of 5'nucleotidase in therapy-resistance of childhood leukemia.
Pieters R; Veerman AJ
Med Hypotheses; 1988 Sep; 27(1):77-80. PubMed ID: 2849709
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
16. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
17. Microscopic esophagitis and Barrett's esophagus: the histology report.
Fiocca R; Mastracci L; Milione M; Parente P; Savarino V; ;
Dig Liver Dis; 2011 Mar; 43 Suppl 4():S319-30. PubMed ID: 21459338
[TBL] [Abstract][Full Text] [Related]
18. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
[TBL] [Abstract][Full Text] [Related]
19. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
